Organogenesis Holdings Inc.
ORGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661181
No open-market purchases or sales by Organogenesis Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $160.4M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Organogenesis Holdings Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 147 | 3 | 121 | −23 |
| Shares | 69.5M | 6.06M | 61.8M | −1.67M (−2.6%) |
| Value | $359.8M | $31.4M | $146.8M | −$181.7M (−55.3%) |
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Organogenesis Holdings Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 2,900,816 | $6.87M | 0.00% |
| Vanguard Portfolio Management LLC | 1,449,092 | $3.43M | 0.00% |
| Sphera Funds Management Ltd. | 550,000 | $1.30M | 0.22% |
| Vanguard Fiduciary Trust Co | 498,452 | $1.18M | 0.00% |
| ExodusPoint Capital Management, LP | 276,914 | $656.3K | 0.01% |
| Tudor Investment Corp Et Al | 63,580 | $150.7K | 0.00% |
| HSBC Holdings PLC | 51,963 | $122.1K | 0.00% |
| SEI Investments Co | 40,244 | $95.4K | 0.00% |
| Vanguard Global Advisers, LLC | 32,763 | $77.6K | 0.00% |
| Prelude Capital Management, LLC | 14,008 | $33.2K | 0.00% |
| Graham Capital Management, L.P. | 13,554 | $32.1K | 0.00% |
| Fifth Third Bancorp | 1,280 | $3.03K | 0.00% |
| MAI Capital Management | 545 | $1.29K | 0.00% |
| Advisory Services Network, LLC | 286 | $678 | 0.00% |
| US Bancorp | 76 | $180 | 0.00% |
| Wealth Preservation Advisors, LLC | 61 | $145 | 0.00% |
Sold out (39)
Institutions that held Organogenesis Holdings Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
Not filed for Q1 2026 yet (3)
Institutions that held Organogenesis Holdings Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 4,958,876 | $25.7M |
| Norges Bank | 1,097,600 | $5.69M |
| Comerica Bank | 1,280 | $6.63K |